Trial Profile
A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief of Patients Status Post-Photorefractive Keratectomy: A Double-Masked Randomized Prospective Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2012
Price :
$35
*
At a glance
- Drugs Nepafenac (Primary) ; Ketorolac
- Indications Postoperative pain
- Focus Therapeutic Use
- 26 May 2012 New trial record